St. Davids, PA, United States of America

Renee Louise Desjarlais

This inventor holds 18 USPTO granted patents and 1 published patent application, plus 6 CIPO patents and 8 EPO patents, primarily in Kinase Inhibition. Top assignee: Janssen Pharmaceutica Nv. Active years: 2008-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Renee Louise Desjarlais. Retrieved from https://idiyas.com/inventor/renee-louise-desjarlais

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 1)

% Patents Active = 38.9

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 8

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 105(Granted Patents)

Company Filing History:

18 out of 2,101

Janssen Pharmaceutica Nv

patents

Years Active: 2008-2016

Loading Chart...

Areas of Expertise:

C-KIT Kinase

c-fms Kinase

Inhibitors

Therapeutics

Cancer Treatment

Targeted Therapy

Pharmaceuticals

Biotechnology

Signal Transduction

Molecular Biology

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9526731 - Method of inhibiting C-KIT kinase (2016-12-27),

2. 9452996 - Inhibitors of c-fms kinase (2016-09-27),

3. 9403804 - Inhibitors of c-fms kinase (2016-08-02),

4. 9394289 - Inhibitors of c-fms kinase (2016-07-19),

5. 9296726 - Inhibitors of c-fms kinase (2016-03-29),

6. 9266866 - Inhibitors of C-FMS kinase (2016-02-23),

7. 9221797 - Inhibitors of c-fms kinase (2015-12-29),

8. 8933091 - Method of inhibiting C-KIT kinase (2015-01-13),

9. 8895584 - Inhibitors of c-fms kinase (2014-11-25),

10. 8859602 - Inhibitors of c-fms kinase (2014-10-14),

11. 8815867 - Inhibitors of c-fms kinase (2014-08-26),

12. 8759347 - Inhibitors of C-FMS kinase (2014-06-24),

13. 8722718 - Inhibitors of C-FMS kinase (2014-05-13),

14. 8481564 - Inhibitors of c-fms kinase (2013-07-09),

15. 7973035 - Inhibitors of C-FMS kinase (2011-07-05),

Title: The Innovative Contributions of Renee Louise Desjarlais

Introduction

Renee Louise Desjarlais is a prominent inventor based in Saint Davids, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for treating various diseases. With a total of 18 patents to her name, her work has had a profound impact on medical science.

Latest Patents

Among her latest patents is a method of inhibiting C-KIT kinase. This invention focuses on reducing or inhibiting kinase activity of C-KIT in a cell or subject, which is crucial for preventing or treating cell proliferative disorders. The compounds developed can be used to treat conditions such as cancers and other related disorders. Another notable patent involves inhibitors of c-fms kinase, which are directed towards compounds that inhibit protein tyrosine kinases. This invention addresses various medical conditions, including autoimmune diseases, inflammatory diseases, and metastasis from several types of cancer.

Career Highlights

Renee is currently associated with Janssen Pharmaceutica NV, where she continues to innovate and contribute to the pharmaceutical industry. Her work has been instrumental in developing treatments for complex diseases, showcasing her expertise and dedication to improving patient outcomes.

Collaborations

Renee has collaborated with notable professionals in her field, including Carl R Illig and Jinsheng Chen. These partnerships have further enhanced her research and development efforts, leading to groundbreaking advancements in medical treatments.

Conclusion

Renee Louise Desjarlais exemplifies the spirit of innovation in the pharmaceutical industry. Her extensive patent portfolio and commitment to addressing critical health issues highlight her significant role as an inventor.

Profile summary based on public USPTO records.